share_log

Things Look Grim For Nanofilm Technologies International Limited (SGX:MZH) After Today's Downgrade

Things Look Grim For Nanofilm Technologies International Limited (SGX:MZH) After Today's Downgrade

在今天的降級之後,納菲爾姆科技國際有限公司(新加坡證券交易所股票代碼:MZH)的情況看起來很嚴峻
Simply Wall St ·  03/03 09:11

One thing we could say about the analysts on Nanofilm Technologies International Limited (SGX:MZH) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the organization. Revenue and earnings per share (EPS) forecasts were both revised downwards, with the analysts seeing grey clouds on the horizon.

關於Nanofilm Technologies International Limited(新加坡證券交易所股票代碼:MZH)的分析師,我們可以說的一件事——他們並不樂觀,他們剛剛對該組織的短期(法定)預測進行了重大負面修正。收入和每股收益(EPS)的預測均向下修正,分析師認爲灰雲即將出現。

After the downgrade, the seven analysts covering Nanofilm Technologies International are now predicting revenues of S$204m in 2024. If met, this would reflect a decent 16% improvement in sales compared to the last 12 months. Per-share earnings are expected to soar 610% to S$0.034. Previously, the analysts had been modelling revenues of S$234m and earnings per share (EPS) of S$0.052 in 2024. It looks like analyst sentiment has declined substantially, with a measurable cut to revenue estimates and a pretty serious decline to earnings per share numbers as well.

降級後,涵蓋納菲爾姆科技國際的七位分析師現在預測2024年的收入爲2.04億新元。如果得到滿足,這將反映出與過去12個月相比銷售額的顯著增長了16%。預計每股收益將飆升610%,至0.034新元。此前,分析師一直在模擬2024年的收入爲2.34億新元,每股收益(EPS)爲0.052新元。看來分析師的情緒已大幅下降,收入預期大幅下調,每股收益數字也嚴重下降。

earnings-and-revenue-growth
SGX:MZH Earnings and Revenue Growth March 3rd 2024
新加坡證券交易所:MZH 收益和收入增長 2024 年 3 月 3 日

It'll come as no surprise then, to learn that the analysts have cut their price target 13% to S$0.74.

因此,得知分析師已將目標股價下調13%至0.74新元也就不足爲奇了。

Of course, another way to look at these forecasts is to place them into context against the industry itself. The analysts are definitely expecting Nanofilm Technologies International's growth to accelerate, with the forecast 16% annualised growth to the end of 2024 ranking favourably alongside historical growth of 7.3% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 11% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Nanofilm Technologies International to grow faster than the wider industry.

當然,看待這些預測的另一種方法是將它們與行業本身聯繫起來。分析師們肯定預計,納菲爾姆科技國際的增長將加速,預計到2024年底的年化增長率爲16%,而過去五年的歷史年增長率爲7.3%。相比之下,我們的數據表明,預計類似行業的其他公司(有分析師報道)的收入將以每年11%的速度增長。顯而易見,儘管增長前景比最近更加光明,但分析師也預計,納菲爾姆科技國際的增長速度將超過整個行業。

The Bottom Line

底線

The most important thing to take away is that analysts cut their earnings per share estimates, expecting a clear decline in business conditions. Unfortunately, analysts also downgraded their revenue estimates, although our data indicates revenues are expected to perform better than the wider market. Given the scope of the downgrades, it would not be a surprise to see the market become more wary of the business.

要了解的最重要的一點是,分析師下調了每股收益預期,預計業務狀況將明顯下降。不幸的是,分析師也下調了收入預期,儘管我們的數據顯示收入表現預計將好於整個市場。考慮到下調評級的範圍,看到市場對該業務變得更加警惕也就不足爲奇了。

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Nanofilm Technologies International analysts - going out to 2026, and you can see them free on our platform here.

話雖如此,公司收益的長期軌跡比明年重要得多。根據多位Nanofilm Technologies International分析師的估計,到2026年,你可以在我們的平台上免費查看。

Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are downgrading their estimates. So you may also wish to search this free list of stocks that insiders are buying.

當然,看到公司管理層將大量資金投資於股票與了解分析師是否在下調預期一樣有用。因此,您可能還希望搜索這份內部人士正在購買的免費股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論